{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000164","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.111855+00:00","generated_at":"2026-05-29T05:12:10.486512+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BeiGene enters $400M unsecured credit facility with China Merchants Bank","bullets":["Facility dated Dec 9, 2024; $400M uncommitted, unsecured, revolving; SOFR-based floating rate.","Proceeds for daily operations and refinancing existing working capital loans.","Company plans to repay $300M of existing $380M drawn facility in Dec 2024; remaining $80M in Jan 2025.","Covenants include liabilities-to-equity ratio, minimum consolidated net assets and cash balance tested quarterly.","No borrowings outstanding under new facility as of filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000164","json":"https://secwatch.observer/filing/0001651308-24-000164.json","markdown":"https://secwatch.observer/filing/0001651308-24-000164.md","text":"https://secwatch.observer/filing/0001651308-24-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000164/0001651308-24-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000164/bgne-20241209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:12:10.486512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}